We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $182M Turnover 8.7%
1-Year Est. Return 26.44%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$191M
AUM Growth
+$14.8M
Cap. Flow
+$4.27M
Cap. Flow %
2.23%
Top 10 Hldgs %
47.22%
Holding
271
New
28
Increased
29
Reduced
43
Closed
22
Avg Time Held
2.3 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
FFIV icon
F5
FFIV
+$5.25M
2
UMPQ
Umpqua Holdings Corp
UMPQ
+$4.89M
3
ORCL icon
Oracle
ORCL
+$2.77M
4
FSLR icon
First Solar
FSLR
+$2.04M
5
GILD icon
Gilead Sciences
GILD
+$467K

Top Sells

Rank Stock Value
1
MGA icon
Magna International
MGA
+$7.44M
2
WFM
Whole Foods Market Inc
WFM
+$3.12M
3
LLY icon
Eli Lilly
LLY
+$1.33M
4
CERN
Cerner Corp
CERN
+$834K
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$766K

Sector Composition

Rank Sector Weight
1 Healthcare 26.37%
2 Technology 20.77%
3 Communication Services 15.92%
4 Industrials 11.33%
5 Financials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IMGN icon
201
DELISTED
Immunogen Inc
IMGN
$7K ﹤0.01%
1,000
– –
2013 Q2
16 quarters
AIG icon
202
American International
AIG
$41.4B
$6K ﹤0.01%
100
– –
2013 Q2
16 quarters
AFL icon
203
Aflac
AFL
$59.2B
$5K ﹤0.01%
124
– –
2014 Q4
10 quarters
DXC icon
204
DXC Technology
DXC
$2.2B
$5K ﹤0.01%
+77
New +$5.11K
2017 Q2
0 quarters
JCI icon
205
Johnson Controls International
JCI
$89.4B
$5K ﹤0.01%
125
– –
2014 Q2
12 quarters
LITE icon
206
Lumentum
LITE
$78.8B
$5K ﹤0.01%
+80
New +$4.29K
2017 Q2
0 quarters
MET icon
207
MetLife
MET
$63.7B
$5K ﹤0.01%
108
– –
2013 Q2
16 quarters
ULBI icon
208
Ultralife
ULBI
$101M
$5K ﹤0.01%
700
– –
2013 Q2
16 quarters
COP icon
209
ConocoPhillips
COP
$170B
$4K ﹤0.01%
100
-92
-48% -$4.29K
2013 Q2
16 quarters
MZTI icon
210
The Marzetti Company
MZTI
$2.82B
$4K ﹤0.01%
30
– –
2014 Q4
10 quarters
MS.PRA icon
211
Morgan Stanley Series A Preferred Stock
MS.PRA
$762M
$4K ﹤0.01%
181
– –
2016 Q4
2 quarters
PSX icon
212
Phillips 66
PSX
$115B
$4K ﹤0.01%
+50
New +$3.92K
2017 Q2
0 quarters
VIAV icon
213
Viavi Solutions
VIAV
$9.05B
$4K ﹤0.01%
+400
New +$4.31K
2017 Q2
0 quarters
STD.PRB
214
DELISTED
SANTANDER FIN PREF SA UNIPERSONAL FTLG RT NON CUM SER 6 GUAR
STD.PRB
$4K ﹤0.01%
165
– –
2016 Q4
2 quarters
EFA icon
215
iShares MSCI EAFE ETF
EFA
$76.9B
$3K ﹤0.01%
40
-40
-50% -$2.59K
2016 Q2
4 quarters
FTV icon
216
Fortive
FTV
$17.5B
$3K ﹤0.01%
68
-165
-71% -$6.49K
2016 Q3
3 quarters
TRST icon
217
Trustco Bank Corp NY
TRST
$920M
$3K ﹤0.01%
71
– –
2013 Q2
16 quarters
TXN icon
218
Texas Instruments
TXN
$255B
$3K ﹤0.01%
40
-328
-89% -$26.3K
2013 Q2
16 quarters
USB.PRH icon
219
US Bancorp Series B Preferred Stock
USB.PRH
$722M
$3K ﹤0.01%
115
– –
2016 Q4
2 quarters
VIVO icon
220
DELISTED
Meridian Bioscience Inc
VIVO
$3K ﹤0.01%
200
– –
2013 Q2
16 quarters
APA icon
221
APA Corp
APA
$16.5B
$2K ﹤0.01%
37
– –
2014 Q4
10 quarters
PBW icon
222
Invesco WilderHill Clean Energy ETF
PBW
$304M
$2K ﹤0.01%
100
– –
2013 Q2
16 quarters
PER
223
DELISTED
PEROT SYSTEMS CORP
PER
$2K ﹤0.01%
650
– –
2013 Q2
16 quarters
HYGS
224
DELISTED
Hydrogenics Corp
HYGS
$2K ﹤0.01%
233
– –
2013 Q2
16 quarters
BBD icon
225
Banco Bradesco
BBD
$45B
$1K ﹤0.01%
16
-1
-6% -$5
2017 Q1
1 quarter
7 8
9
10 11

Similar funds

TA
TPG Advisors Northfield, Illinois $182M AUM 18.36% 1-Year Est. Return
LAM
Lakewood Asset Management Naperville, Illinois $182M AUM 22.41% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $182M AUM 21.95% 1-Year Est. Return
FNBOH
First National Bank of Hutchinson Hutchinson, Kansas $182M AUM 38.15% 1-Year Est. Return
SIM
Sterling Investment Management Tucson, Arizona $182M AUM 9.75% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
PW
PUREfi Wealth Boston, Massachusetts $182M AUM 26.04% 1-Year Est. Return
DRC
Darwins River Capital New York $182M AUM

Prentiss Smith & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Prentiss Smith & Co held 271 positions worth $191M, up 8.4% from $176M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Prentiss Smith & Co's Q2 2017 filing shows 28 new, 29 increased, 43 reduced and 22 closed positions. Its largest new stake was Gilead Sciences: 7,018 shares worth $497K. The largest sale was Magna International, an estimated $7.44M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

  • Prentiss Smith & Co's largest Q2 2017 buy was Gilead Sciences: 7,018 shares worth $497K.
  • Prentiss Smith & Co added most to F5 in Q2 2017, an estimated $5.25M increase.
  • Prentiss Smith & Co's biggest Q2 2017 reduction was Whole Foods Market Inc, cutting an estimated $3.12M.
  • Prentiss Smith & Co fully exited Magna International in Q2 2017, selling an estimated $7.44M.
  • Prentiss Smith & Co's ten largest holdings make up 47% of its $191M portfolio in Q2 2017.
  • Prentiss Smith & Co opened 28 new positions and closed 22 in Q2 2017.
  • Prentiss Smith & Co's portfolio value rose 8.4% quarter-over-quarter to $191M.

Based on Prentiss Smith & Co's 13F filing for Q2 2017, filed 10 Jul 2017.